Calcified Chondroid Mesenchymal Neoplasms

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Calcified chondroid mesenchymal neoplasms (CCMN) present a spectrum of related tumors.
• Historically, chondroid matrix or chondroblastoma-like features were noted in soft tissue chondroma, tenosynovial giant cell tumors (especially in the TMJ region), and tophaceous pseudogout.
• These morphologic similarities often led to diagnostic challenges.

Purpose of the Study:

• To review the clinical, morphologic, immunohistochemical, and molecular genetic features of CCMN.
• To highlight the shared FN1-receptor tyrosine kinase (RTK) fusions in these neoplasms.
• To provide guidance on distinguishing CCMN from morphologic mimics.

Main Methods:

• Comprehensive literature review of CCMN.
• Analysis of clinical presentation and imaging findings.
• Histopathological and immunohistochemical evaluation.
• Molecular genetic analysis, focusing on FN1-RTK fusions.

Main Results:

• CCMN encompass a range of tumors previously considered distinct entities.
• A unifying feature identified is the presence of FN1-receptor tyrosine kinase (RTK) fusions.
• Distinctive immunohistochemical and morphologic profiles aid in differentiation from mimics.

Conclusions:

• CCMN represent a biologically related group of tumors unified by specific genetic alterations.
• Recognition of shared FN1-RTK fusions is crucial for accurate diagnosis and classification.
• Understanding these features improves diagnostic accuracy and distinguishes CCMN from similar-appearing lesions.